Cite

HARVARD Citation

    Chu, A. et al. (n.d.). 321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis. British journal of dermatology. p. . [Online]. 
  
Back to record